3
Announcements
Trials
Browse
Landscape
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Neoplasms
10
Lung Neoplasms
9
Colorectal Neoplasms
7
Breast Neoplasms
7
Prostatic Neoplasms
6
Rectal Neoplasms
3
Polycystic Ovary Syndrome
3
Neoplasm Metastasis
3
Colonic Neoplasms
3
Stomach Neoplasms
2
Smoking Cessation
2
Neoplastic Cells, Circulating
2
Motor Activity
2
Lymphoma
2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
Leukemia
2
Endometrial Neoplasms
2
Disease
2
Carcinoma, Non-Small-Cell Lung
2
Carcinoma, Hepatocellular
2
Venous Thromboembolism
1
Vaginal Neoplasms
1
Uveal Melanoma
1
Uterine Cervical Neoplasms
1
Untreated Human Epidermal Growth Factor Receptor-2(HER2)Positive Early Breast Cancer
1
Testicular Germ Cell Tumor
1
Stroke
1
Solitary Pulmonary Nodule
1
Skin Neoplasms
1
Sezary Syndrome
1
Interventions
Filgrastim
4
Carboplatin
4
Thiotepa
3
Peripheral Blood Stem Cell Transplantation
3
Etoposide
3
etoposide phosphate
2
Paclitaxel
2
Ifosfamide
2
Granulocyte Colony-Stimulating Factor
2
Taxes
1
Radiotherapy
1
Microarray Analysis
1
Mesna
1
Melphalan
1
Immunohistochemistry
1
Hematologic Tests
1
Dasatinib
1
Cyproheptadine
1
Cyclophosphamide
1
Cisplatin
1
Busulfan
1
Bone Marrow Transplantation
1
Blotting, Western
1
Bleomycin
1
Arsenic Trioxide
1
Amifostine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Ovarian Germ Cell Cancer
×
Hematologic Tests
×
Clear all
NCT06329323
2024-03-26
SUMMER
Imperial College London
Not yet recruiting
24 enrolled